Led by the American Clinical Laboratory Association (ACLA), over 60 public health organizations representing patients, health care professionals, hospitals, public health, laboratories, and diagnostic manufacturers have sent a letter urging the U.S. Congress to replenish the HRSA COVID-19 Uninsured Relief Fund.Click here to view the letter sent by the ACLA and others to Congressional leadership.The Health

Throughout the pandemic, Aculabs has worked to meet the demand for ample COVID-19 specimen collection kits. Adequate access to such supplies remains highly important for physicians in catching COVID-19 early on in vulnerable populations. Clients who have received COVID-19 collection kits from Aculabs should continue using the kits provided, even tubes that display a

The start of 2022 saw Aculabs roll out several new features to our online web portal, including Email Reporting for Result Notification and improved logic used in our Exception Test Flagging feature. The purpose of such features is to continue expanding the ways in which Aculabs communicates with your staff while tackling patient care

Aculabs will be offering QuantiFERON-TB Gold Plus in-house as of April 6, 2022; the test provides highly accurate and reproducible results, single-step testing, and innovative CD8 T cell technology that provides a more comprehensive view of the immune response to TB infection. Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health

Please be aware that several send-out tests will be temporarily unavailable to order, as supply shortages impacting the grey and pink parapak kits used for the collection of stool specimen have impacted the reference laboratories in which Aculabs utilizes for such send-out testing. The following are the most commonly ordered tests to be impacted:

As an industry leader, Aculabs values the way in which our digital and technological systems can always be improved to continually optimize the user experience. Our Online Web Portal remains the main hub for which many clients can 1) most easily place orders and 2) receive order results in the shortest time possible, necessary

In a new memo, the United States Food & Drug Administration (FDA) has documented and warned both patients and healthcare providers of the risk of Omicron, the latest variant of SARS-CoV-2, displaying reduced sensitivity to rapid antigen tests. Rapid antigen tests, sometimes referred to as lateral flow tests, are often used in occupational and

What is the status of the CMS Vaccine Mandate at present? The United States District Court in the Western District of Louisiana has issued a nationwide injunction preventing the federal government from implementing the CMS vaccine mandate for health care staff. This injunction applies to all states which were not covered by the injunction issued yesterday in ten states,

Currently, the B16172 (Delta) variant, the B117 (Alpha) variant, the P1 (Gamma), and B1526 (NY variant) have been reported in New Jersey, but make way for the new one B.1.1.529 also known as Omicron - named for the 15th letter of the greek alphabet. This past Sunday, the WHO said it is not yet clear

In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing